Ethypharm (Omeprazole and Ketoprofen products) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Ethypharm (Omeprazole and Ketoprofen products) General Information

Description

A portfolio of gastrointestinal problems treating product line. The product line consists of omeprazole (proton pump inhibitor) and ketoprofen (nonsteroidal anti-inflammatory drug) that come in the form of a capsule and offers protection against nonsteroidal anti-inflammatory drug's side effects and mucosal injuries.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Acquirer
Corporate Office
  • 194, Bureaux de la Colline
  • 92213 Saint-Cloud
  • France

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ethypharm (Omeprazole and Ketoprofen products) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ethypharm (Omeprazole and Ketoprofen products)‘s full profile, request access.

Request a free trial

Ethypharm (Omeprazole and Ketoprofen products) FAQs

  • Where is Ethypharm (Omeprazole and Ketoprofen products) headquartered?

    Ethypharm (Omeprazole and Ketoprofen products) is headquartered in Saint-Cloud, France.

  • What industry is Ethypharm (Omeprazole and Ketoprofen products) in?

    Ethypharm (Omeprazole and Ketoprofen products)’s primary industry is Buildings and Property.

  • Is Ethypharm (Omeprazole and Ketoprofen products) a private or public company?

    Ethypharm (Omeprazole and Ketoprofen products) is a Private company.

  • What is the current valuation of Ethypharm (Omeprazole and Ketoprofen products)?

    The current valuation of Ethypharm (Omeprazole and Ketoprofen products) is 00.00.

  • What is Ethypharm (Omeprazole and Ketoprofen products)’s current revenue?

    The current revenue for Ethypharm (Omeprazole and Ketoprofen products) is 000000.

  • When was Ethypharm (Omeprazole and Ketoprofen products) acquired?

    Ethypharm (Omeprazole and Ketoprofen products) was acquired on 10-May-2007.

  • Who acquired Ethypharm (Omeprazole and Ketoprofen products)?

    Ethypharm (Omeprazole and Ketoprofen products) was acquired by Meda.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »